| |
Partin tables - A set of tables published by Alan Partin from Johns Hopkins that uses preoperative PSA, Gleason score, and clinical stage to predict the pathologic stage of prostate cancer from a radical prostatectomy specimen.
Pelvic lymph node dissection - Removal of the lymph nodes adjacent to the prostate.
Peripheral zone (PZ)- Outer area of prostate where over 80% of prostate cancers originate.
Peyronie’s disease - scar tissue build up inside the penis causing curvature, narrowing os shortening of an erect penis
Positive predictive value (PPV) - Proportion of true positive tests when a modality gives a positive test result.
|
|
Priapism - Prolonged and often painful penile erections not associated with sexual stimulation
Prostascint® - A monoclonal antibody imaging study used to detect prostate cancer cells throughout the soft tissues of the body.
Prostate cancer - Cancer involving the prostate gland; the cause of prostate cancer remains unknown
Prostate gland - A gland in the male which surrounds the neck of the bladder and urethra. The prostate contributes to the seminal fluid. Prostate specific antigen (PSA) - A protein that is specifically manufactured by prostatic epithelial cells. The level of PSA often correlates with the likelihood and extent of prostate cancer and the size of benign prostatic enlargement or BPH.
|
|
Prostate specific membrane antigen - An antigen present on the cell membrane of prostatic epithelial cells.
Prostatectomy -Removal of the protate.
Prostatic intraepithelial neoplasia (PIN) - A precancerous lesion of the prostate that often accompanies prostatic cancer.
Protein -Any of a group of complex organic compounds which contain carbon, hydrogen, oxygen and nitrogen. Proteins are made of amino acids.
Pyeloplasty -Repair of ureteropelvic junction obstruction. |